Page 290 - Medicare Benefit Policy Manual
P. 290

The HCPCS codes are:

                       •  G0420:  Face-to-face educational services related to the care of chronic kidney
                          disease; individual, per session, per one hour

                       •  G0421:  Face-to-face educational services related to the care of chronic kidney
                          disease; group, per session, per one hour

                   310.4 – Standards for Content
                   (Rev. 117; Issued:  12-18-09; Effective Date:  01-01-10; Implementation Date:  04-
                   05-10)

                   Medicare Part B covers KDE services, provided by a qualified person, which provide
                   comprehensive information regarding:

                       A. The management of comorbidities, including delaying the need for dialysis, which
                           includes, but is not limited to, the following topics:

                       •  Prevention and treatment of cardiovascular disease,

                       •  Prevention and treatment of diabetes,
                       •  Hypertension management,
                       •  Anemia management,
                       •  Bone disease and disorders of calcium and phosphorus metabolism management,

                       •  Symptomatic neuropathy management, and
                       •  Impairments in functioning and well-being.


                       B. Prevention of uremic complications, which includes, but is not limited to, the
                           following topics:

                       •  Information on how the kidneys work and what happens when the kidneys fail,
                       •  Understanding if remaining kidney function can be protected, preventing disease
                           progression, and realistic chances of survival,
                       •  Diet and fluid restrictions, and
                       •  Medication review, including how each medication works, possible side effects
                           and minimization of side effects, the importance of compliance, and informed
                           decision making if the patient decides not to take a specific drug.

                       C. Therapeutic options, treatment modalities and settings, advantages and
                           disadvantages of each treatment option, and how the treatments replace the
                           kidney, including, but not limited to, the following topics:

                       •  Hemodialysis, both at home and in-facility;
   285   286   287   288   289   290   291   292   293   294   295